# IGC Pharma, Inc.: Form 8-K, filed Jun 5, 2014

- Company: [IGC Pharma, Inc.](/companies/igc.md) (CIK 1326205)
- Form: 8-K
- Filed: 2014-06-05
- Accepted by EDGAR: Jun 4, 2014, 17:55 ET
- Period: 2014-05-31
- Accession: 0001185185-14-001526
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1326205/000118518514001526/indiaglobal8k060414.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1326205/000118518514001526/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.01: Completion of an acquisition or disposition
- Item 3.02: Unregistered sale of equity
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1326205/000118518514001526/indiaglobal8k060414.htm

Filed Jun 5, 2014.
Source: SEC EDGAR, the filing index for accession 0001185185-14-001526. Last ingested by Listed: Nov 6, 2026, 16:27 ET. No prices; not investment advice.
